Annals of Oncology 14:1193-1195, 2003
© 2003 European Society for Medical Oncology
Original Paper |
EUSOMA review of mammography screening
Cancer Research UK & UCL Cancer Trials Centre, University College London, London, UK
Received 12 July; accepted 3 April 2003
In 1993 the European Society of Mastology concluded that regular mammography screening reduces the risk of dying from breast cancer. The evidence came from a meta-analysis of six randomised controlled trials that collectively showed a statistically significant 22% reduction in breast cancer mortality. The effect is clear in women aged
50 years but there is uncertainty in women aged <50 years. Screening programmes for women aged
50 years should be part of organised public health programmes. The adverse effects of screening were addressed and performance indicators of programmes were specified.
Key words: breast cancer, mammography, review, screening
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. E. Jacobi, N. J.D. Nagelkerke, J. C. van Houwelingen, and G. H. de Bock Breast Cancer Screening, Outside the Population-Screening Program, of Women from Breast Cancer Families without Proven BRCA1/BRCA2 Mutations: a Simulation Study. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 429 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boyle Global summit on mammographic screening Ann. Onc., August 1, 2003; 14(8): 1159 - 1160. [Full Text] [PDF] |
||||

